1. Analysis of pathological complete response rates with paclitaxel-based regimens in trimodality therapy for esophageal cancer. Issue 7 (1st October 2015) Authors: Boggs, D. H.; Tarabolous, C.; Morris, C. G.; Hanna, A.; Burrows, W.; Horiba, N.; Suntharalingam, M. Journal: Diseases of the esophagus Issue: Volume 28:Issue 7(2015) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of pathological complete response rates with paclitaxel‐based regimens in trimodality therapy for esophageal cancer. Issue 7 (26th May 2014) Authors: Boggs, D. H.; Tarabolous, C.; Morris, C. G.; Hanna, A.; Burrows, W.; Horiba, N.; Suntharalingam, M. Journal: Diseases of the esophagus Issue: Volume 28:Issue 7(2015) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0356 The Therapeutic Efficacy of the Novel Uricosuric Agent UR-1102 for Hyperuricemia and Gout. (23rd January 2014) Authors: Ahn, S. O.; Horiba, N.; Ohtomo, S.; Lee, K. J.; Kim, K. H.; Kim, B. H.; Kiyokawa, J.; Yamane, M.; Ikegami, H.; Nakagawa, T.; Hwang, H.-H.; Park, J.-H.; Cha, J. Y.; Tanaka, J.; Kake, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗